Home » Advocacy » Federal Government Relations

Federal Government Relations

The 340B Drug Discount Program
February 12, 2013

Congress created the 340B program in 1992 to help uninsured indigent patients gain better...

BIO's 2013 Legislative Priorities
January 21, 2013

Brent Del Monte, BIO’s Vice President of Federal Government Relations, discusses the...

Biofuels Power the Great Green Fleet
July 18, 2012

LtGen John "Glad" Castellaw explains how the U.S. military will validate the use of...

Therapeutic Discovery Project Defending America's Competitiveness in Biotechnology
April 9, 2012

Capital formation challenges in the industry have forced many biotech companies to halt...

More Articles →

Letters, Testimony & Comments

Pandemic and All-Hazards Preparedness Reauthorization Act
December 18 2012
Dear Speaker Boehner and Minority Leader Pelosi: On behalf of the Biotechnology Industry Organization (BIO), I am writing with our...
The Renewable Fuels Standard: A Successful Federal Policy that Must Be Defended
October 17 2012
A keynote Address by James C. Greenwood, President & CEO of BIO, to RETECH 2012 in Washington, DC on October 18, 2012. When Admiral...
IP Attache Program: BIO's Congressional Hearing Comments
June 27 2012
  The U.S. Intellectual Property Rights Attaché Program has had significant success and holds immense promise in helping to...
Oppose Costly & Confusing Labeling Amendment to the Agriculture Reform, Food and Jobs Act of 2012
June 21 2012
Senators Sanders and Boxer have introduced an amendment that will result in costly and extreme food labeling requirements. Senate...
The Farm Bill: BIO Opposes the Sanders-Boxer Amendment
June 21 2012
The Biotechnology Industry Organization (BIO), which represents more than 1,100 biotechnology companies, academic institutions, state...
More Letters, Testimony & Comments →

Press Releases

BIO Praises U.S. Senate for Passing the Pandemic and All-Hazards Preparedness Reauthorization Act
February 28 2013
WASHINGTON, DC – February 28, 2013 –The Biotechnology Industry Organization (BIO) lauds the Senate for...
BIO Praises Introduction of the High Technology Small Business Research Incentives Act
September 25 2012
Washington, D.C. (September 25, 2012) – The Biotechnology Industry Organization (BIO) applauds Sens. Robert...
BIO Submits Comments on FDA Draft Guidances on Biosimilars
April 17 2012
Washington, D.C. (April 17, 2012) – The Biotechnology Industry Organization (BIO) submitted comments yesterday...
BIO Applauds Congress for Passage of the Jumpstart Our Business Startups (JOBS) Act
March 27 2012
The Biotechnology Industry Organization (BIO) praises the House and Senate for passage of H.R. 3606, the Jumpstart...
Biotech Leader Provides Testimony at Congressional Hearing on ‘Spurring Job Growth through Capital Formation While Protecting Investors’
March 6 2012
Today, the Senate Committee on Banking, Housing, and Urban Affairs held a hearing on “Spurring Job Growth...
More Press Releases →